Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway

European Journal of Endocrinology

Volumn 149, Issue 4, 2003, Pages 287-292

  Georgopoulos, Neoklis A ^a   Sykiotis, Gerasimos P ^a   Sgourou, Argyro ^a   Papachatzopoulou, Adamantia ^a   Markou, Kostas B ^a   Kyriazopoulou, Venetsana ^a   Papavassiliou, Athanasios G ^a   Vagenakis, Apostolos G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; IODINE; PROTEIN G; THYROTROPIN; THYROTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GREECE; HETEROZYGOTE DETECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IODINE DEFICIENCY; MALE; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NODULAR GOITER; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYROID ADENOMA; THYROID FUNCTION; THYROIDECTOMY; TOXIC GOITER;

ADENOMA; ADULT; AGED; ENDEMIC DISEASES; FEMALE; GOITER, NODULAR; GREECE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPERPLASIA; IODINE; MALE; MIDDLE AGED; MUTATION; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROID NODULE; THYROIDECTOMY; THYROTROPIN;

EID: 0142247465     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490287     Document Type: Article

References (38)

1. Dumont JE, Lamy F, Roger P & Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Reviews 1992 72 667-697.
2. Nagayama Y & Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Molecular Endocrinology 1992 6 145-156.
3. Kopp P. The TSH receptor and its role in thyroid disease. Cellular and Molecular Life Sciences 2001 58 1301-1322.
4. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE et al. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. PNAS 1996 93 116-120.
5. Leflowitz RJ, Cotecchia S, Samama P & Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends in Pharmacological Science 1993 14 303-307.
6. Siegel RD & Lee SL. Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter. Endocrinology and Metabolism Clinics of North America 1998 27 151-168.
7. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H et al. Two G protein oncogenes in human endocrine tumors. Science 1990 249 655-659.
8. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993 365 649-651.
9. Vassart G. New pathophysiological mechanisms for hyperthyroidism. Hormone Research 1997 48 (Suppl 4) 47-50.
10. Govaerts C, Lefort A, Costagliola S, Wodak SJ, Ballesteros JA, Van Sande J et al. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. Journal of Biological Chemistry 2001 276 22991-22999.
11. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA & Paschke R. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. Journal of Clinical Endocrinology and Metabolism 1997 82 4229-4233.
12. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F et al. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. Journal of Clinical Endocrinology and Metabolism 1998 83 492-498.
13. Dremier S, Coppee F, Delange F, Vassart G, Dumont JE & Van Sande J. Clinical review 84: Thyroid autonomy: mechanisms and clinical effects. Journal of Clinical Endocrinology and Metabolism 1996 81 4187-4193.
14. Hedinger C, Williams ED & Sobin LH. Histological typing of thyroid tumors. In WHO International Histological Classification of Tumors, pp 5-6. Berlin: Springer, 1988.
15. Tonacchera M, Vitti P, Agretti P, Giulianetti B, Mazzi B, Cavaliere R et al. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid 1998 8 559-564.
16. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A et al. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. Journal of Clinical Endocrinology and Metabolism 2000 85 2270-2274.
17. Russo D, Arturi F, Chiefari E & Filetti S. Thyrotropin receptor: a role for thyroid tumourigenesis? Forum 1999 9 166-175.
18. Gromoll J, Brocker M, Derwahl M & Hoppner W. Detection of mutations in glycoprotein hormone receptors. Methods 2000 21 83-97.
19. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F et al. Detection of thyroid-stimulating hormone receptor and Gs alpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. Journal of Molecular Medicine 2000 78 684-691.
20. Derwahl M. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas - a note of caution. Journal of Clinical Endocrinology and Metabolism 1996 81 2783-2785.
21. Koutras DA, Piperingos G, Mantzos J, Boukis M, Karaiskos KS & Hadjiioannou S. Iodine nutrition and iodine deficiency disorders in Greece: signs of improvement. In Iodine Deficiency in Europe, pp 421-426. Eds F Delange, JT Dunn & D Glinoez. New York: Plenum Press, 1993.
22. Doufas AG, Mastorakos G, Chatziioannou S, Tseleni-Balafouta S, Piperingos G, Boukis MA et al. The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. European Journal of Endocrinology 1999 140 505-511.
23. Markou K, Michalaki M, Makri M, Georgopoulos N, Pagoni C, Sorras K et al. Iodine intake and thyroid function in villagers and city dwellers in Southwestern Greece (SWG). Thyroid 1996 6 (Suppl 1) 79.
24. Corvilain B, Van Sande J, Dumont JE, Bourdoux P & Ermans AM. Autonomy in endemic goiter. Thyroid 1998 8 107-113.
25. de Roux N, Misrahi M, Chatelain N, Gross B & Milgrom E. Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene. Molecular and Cellular Endocrinology 1996 117 253-256.
26. αs by a gain-of-function mutant but not by the wild-type receptor. Biochemical and Biophysical Research Communications 2003 301 1051-1056.
27. Tonaccherra M & Pinchera A. Thyrotropin receptor polymorphisms and thyroid diseases. Journal of Clinical Endocrinology and Metabolism 2000 85 2637-2639.
28. Trulzsch B, Krohn K, Wonerow P & Paschke R. DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. BioTechniques 1999 27 266-268.
29. Kosugi S, Hai N, Okamoto H, Sugawa H & Mori T. A novel activating mutation in the thyotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. European Journal of Endocrinology 2000 143 471-477.
30. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove L, Parma J et al. Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. European Journal of Endocrinology 2002 147 287-291.
31. Bray EA. Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. Journal of Clinical Investigation 1968 47 1640-1647.
32. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont JE et al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Letters 1997 409 469-474.
33. Wonerow P, Schoneberg T, Schultz G, Gudermann T & Paschke R. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. Journal of Biological Chemistry 1998 273 7900-7905.
34. Szkudlinski MW, Fremont V. Ronin C & Weintraub BD. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiological Reviews 2002 82 473-502.
35. Wonerow P, Neumann S, Gudermann T & Pashke R. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. Journal of Molecular Medicine 2001 79 707-721.
36. Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG et al. A somatic activating mutation in the thyrotropin receptor gene in a patient with an autonomous nodule within a multinodular goiter. Hormones 2002 1 42-46.
37. Studer H & Derwahl M. Mechanisms of nonneoplastic endocrine hyperplasia - a changing concept: a review focused on the thyroid gland. Endocrine Reviews 1995 16 411-426.
38. Derwahl M & Studer H. Hyperplasia versus adenoma in endocrine tissues: are they different? Trends in Endocrinology and Metabolism 2002 13 23-28.